World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on November 4, 2026

The 2026 Top 25 Historic Hotels Worldwide® Afternoon Tea Experiences List is Announced
VapoCept Official Website Publishes a New Guide to VapoCept Ingredients L-Arginine AKG and Citrulline
The Global Aspergillosis Treatment Market is Projected to Exceed $4.58 Billion by 2030
The At-Home Genetic Testing Market Is Projected to Grow at a 15.5% CAGR by 2030
Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference
Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
Cerenome Secures National In-Network Agreement with Aetna for CNSide®
Medline Reports Third Quarter and Nine Months 2026 Results
Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile
Immuneering to Highlight Atebimetinib’s Broad Potential for Combinations in Pancreatic and Anaplastic Thyroid Cancers at the 2026 EORTC-NCI-AACR Symposium
MediPharm Labs Appoints Greg Hunter as Chief Executive Officer and Director
Sentinel Risk Group Expands Its AI Risk Assessment for Medical and Behavioral Health Practices
Kane Announces Publication of Real-World Evidence in the International Wound Journal
uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update
Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
AC Immune Third Quarter 2026 Financial and Corporate Update
MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update
Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.